Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants

European Journal of Internal Medicine

Volumn 25, Issue 6, 2014, Pages 566-570

  Del Ben, M ^a   Polimeni, L ^a   Brancorsini, M ^a   Di Costanzo, A ^a   D'Erasmo, L ^a   Baratta, F ^a   Loffredo, L ^a   Pastori, D ^a   Pignatelli, P ^a   Violi, F ^a   Arca, M ^a   Angelico, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Metabolic syndrome; Non alcoholic fatty liver disease; PNPLA3

Indexed keywords

TRIACYLGLYCEROL; ADIPONUTRIN, HUMAN; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; DISEASE SEVERITY; FEMALE; FRAMINGHAM RISK SCORE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING PROTEIN 3 GENE; PREVALENCE; RISK REDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; AGED; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; ECHOGRAPHY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPASE; MALE; MEMBRANE PROTEINS; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 84903378975     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2014.05.012     Document Type: Article

References (31)

1. C.E. Ruhl, and J.E. Everhart Epidemiology of nonalcoholic fatty liver Clin Liver Dis 8 2004 501 519
2. G. Bedogni, L. Miglioli, F. Masutti, C. Tiribelli, G. Marchesini, and S. Bellentani Prevalence of risk factors for non-alcoholic fatty liver disease: the Dionysos Nutrition and Liver Study Hepatology 42 2005 44 52
3. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219
4. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
5. C.P. Day Pathogenesis of steatohepatitis Best Pract Res Clin Gastroenterol 16 2002 663 678
6. J.P. Despres, I. Lemieux, and J. Bergeron et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk Arterioscler Thromb Vasc Biol 28 2008 1039 1049
7. S. Mottillo, K.B. Filion, and J. Genest et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis J Am Coll Cardiol 56 2010 1113 1132
8. G. Targher, C.P. Day, and E. Bonora Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease N Engl J Med 363 2010 1341 1350
9. M. Del Ben, F. Baratta, L. Polimeni, and F. Angelico Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences Intern Emerg Med 7 2012 S291 S296
10. G. Targher, F. Marra, and G. Marchesini Increased risk of cardiovascular disease in nonalcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 51 2008 1947 1953
11. Y.C. Lin, H.M. Lo, and J.D. Chen Sonographic fatty liver, overweight and ischemic heart disease World J Gastroenterol 11 2005 4838 4842
12. S.A. Mirbagheri, A. Rashidi, S. Abdi, D. Saedi, and M. Abouzari Liver: an alarm for the heart? Liver Int 27 2007 891 894
13. F. Angelico, M. Del Ben, and R. Conti et al. Non alcoholic fatty liver disease: an hepatic consequence of common metabolic diseases J Gastroenterol Hepatol 18 2003 588 594
14. A. Kotronen, and H. Yki-Järvinen Fatty liver: a novel component of the metabolic syndrome Arterioscler Thromb Vasc Biol 28 2008 27 38
15. F. Angelico, M. Del Ben, and R. Conti et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease J Clin Endocrinol Metab 90 2005 1578 1582
16. S. Lallukka, K. Sevastianova, and J. Perttilä et al. Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3 Diabetologia 56 2013 886 892
17. S.M. Zain, R. Mohamed, and S. Mahadeva et al. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease Hum Genet 131 2012 1145 1152
18. K. Kantartzis, A. Peter, and F. Machicao et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene Diabetes 58 2009 [2616-2]
19. M.I. Goran, R. Walker, and K.A. Le et al. Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents Diabetes 59 2010 [3127-3]
20. E.K. Speliotes, J.L. Butler, and C.D. Palmer et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease Hepatology 52 2010 904 912
21. S. Sookoian, and C.J. Pirola Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease Hepatology 53 2011 1883 1894
22. C. Dubuquoya, A.F. Burnola, and M. Moldesa PNPLA3, a genetic marker of progressive liver disease, still hiding its metabolic function? Clin Res Hepatol Gastroenterol 37 2012 30 35
23. J. Shen, G.L. Wong, and H.L. Chan et al. PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome Aliment Pharmacol Ther 39 2014 532 539
24. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 34 2011 S62 S69
25. S.M. Grundy, J.I. Cleeman, and S.R. Daniels et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
26. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
27. M. Hamaguchi, T. Kojima, and Y. Itoh et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation Am J Gastroenterol 102 2007 2708 2715
28. S.H. Saverymuttu, A.E.A. Joseph, and J.D. Maxwell Ultrasound scanning in the detection of hepatic fibrosis and steatosis Br Med J 292 1986 13 15
29. C.W. Wang, H.Y. Lin, and S.J. Shin et al. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population Liver Int 31 2011 1326 1331
30. C.Y. Chang Understanding the relationship between PNPLA3, NAFLD and insulin resistance: do ethnic differences bring more questions or more answers? Liver Int 31 2011 1246 1249
31. C. Pirazzi, M. Adiels, and M.A. Burza et al. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro J Hepatol 57 2012 1276 1282